Recently, it has been suggested that tissue expression of ACE2, the receptor for SARS-CoV-2, in the lungs and gastrointestinal tract is regulated by signaling through the nuclear receptor FXR (farnesoid X receptor), and thus FXR signaling may be a potential therapeutic target for COVID-19 [39]. The gene discussed is NR1H4; the disease is COVID-19.